Emergency use of drugs authorised for COVID-19

US to allow hydroxychloroquine and chloroquine from national stockpile to be distributed and used for certain hospitalised patients infected with COVID-19 The Food and Drug Administration (FDA) in the United States has decided that the benefits of using hydroxychloroquine and chloroquine to treat COVID-19 patients outweigh the risks, despite clinical trials having not yet been